InvestorsHub Logo
Followers 5
Posts 1279
Boards Moderated 0
Alias Born 04/15/2019

Re: yada202 post# 6812

Thursday, 03/11/2021 12:53:00 AM

Thursday, March 11, 2021 12:53:00 AM

Post# of 7496
When Recell gets approved in Japan, I wonder if Avita can use the data that it will accumulate from Japanese patients that are treated for vitiligo, diabetic foot ulcers and venous leg ulcers, to speed up the U.S. FDA approval process for those treatments?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RCEL News